Vis enkel innførsel

dc.contributor.authorHofmann, Bjørn
dc.date.accessioned2019-04-30T10:14:32Z
dc.date.available2019-04-30T10:14:32Z
dc.date.created2018-06-28T14:13:25Z
dc.date.issued2018
dc.identifier.citationMedicine, Health care and Philosophy. 2018, 21 (3), 295-302.nb_NO
dc.identifier.issn1386-7423
dc.identifier.urihttp://hdl.handle.net/11250/2596098
dc.description.abstractNew emerging biotechnologies, such as gene editing, vastly extend our ability to alter the human being. This comes together with strong aspirations to improve humans not only physically, but also mentally, morally, and socially. These conjoined ambitions aggregate to what can be labelled “the gene editing of super-ego.” This article investigates a general way used to argue for new biotechnologies, such as gene-editing: if it is safe and efficacious to implement technology X for the purpose of a common good Y, why should we not do so? This is a rhetorical question with a conditional, and may be dismissed as such. Moreover, investigating the question transformed into a formal argument reveals that the argument does not hold either. Nonetheless, the compelling force of the question calls for closer scrutiny, revealing that this way of arguing for biotechnology is based on five assumptions. Analysis of these assumptions shows their significant axiological, empirical, and philosophical challenges. This makes it reasonable to claim that these kinds of question based promotions of specific biotechnologies fail. Hence, the aspirations to make a super-man with a super-ego appear fundamentally flawed. As these types of moral bioenhancement arguments become more prevalent, a revealing hype test is suggested: What is special with this technology (e.g., gene editing), compared to existing methods, that makes it successful in improving human social characteristics in order to make the world a better place for all? Valid answers to this question will provide good reasons to pursue such technologies. Hence, the aim is not to bar the development of modern biotechnology, but rather to ensure good developments and applications of highly potent technologies. So far, we still have a long way to go to make persons with goodness gene(s).nb_NO
dc.language.isoengnb_NO
dc.publisherSpringer Verlagnb_NO
dc.titleThe gene-editing of super-egonb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber295-302nb_NO
dc.source.volume21nb_NO
dc.source.journalMedicine, Health care and Philosophynb_NO
dc.source.issue3nb_NO
dc.identifier.doi10.1007/s11019-018-9836-z
dc.identifier.cristin1594523
dc.description.localcodeThis is a post-peer-review, pre-copyedit version of an article published in [Medicine, Health care and Philosophy] Locked until 17.4.2019 due to copyright restrictions. The final authenticated version is available online at: https://doi.org/10.1007/s11019-018-9836-znb_NO
cristin.unitcode194,65,70,0
cristin.unitnameInstitutt for helsevitenskap Gjøvik
cristin.ispublishedtrue
cristin.fulltextpreprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel